Mechanism underlying resistance of human pancreatic beta cells against toxicity of streptozotocin and alloxan [5]

Diabetologia

Volumn 46, Issue 12, 2003, Pages 1713-1714

  Elsner, M ^a   Tiedge, M ^a   Lenzen, S ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; GLUCOSE TRANSPORTER 2; STREPTOZOCIN;

ANTIOXIDANT ACTIVITY; DIABETOGENESIS; GENE EXPRESSION; HUMAN; HUMAN CELL; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LETTER; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ALLOXAN; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORTER TYPE 2; HUMANS; IMMUNITY, NATURAL; ISLETS OF LANGERHANS; MONOSACCHARIDE TRANSPORT PROTEINS; STREPTOZOCIN;

EID: 0346216152     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1241-2     Document Type: Letter

References (12)

1. Rerup CC (1970) Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol Rev 22: 485-518
2. Eizirik DL, Pipeleers DG, Ling Z, Welsh N, Hellerstrom C, Andersson A (1994) Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc Natl Acad Sci USA 91: 9253-9256
3. Tyrberg B, Andersson A, Borg LA (2001) Species differences in susceptibility of transplanted and cultured pancreatic islets to the beta-cell toxin alloxan. Gen Comp Endocrinol 122: 238-251
4. Yang H, Wright JR (2002) Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 143: 2491-2495
5. Elsner M, Guldbakke B, Tiedge M, Munday R, Lenzen S (2000) Relative importance of transport and alkylation for pancreatic beta-cell toxicity of streptozotocin. Diabetologia 43: 1528-1533
6. Elsner M, Tiedge M, Guldbakke B, Munday R, Lenzen S (2002) Importance of the GLUT2 glucose transporter for pancreatic beta-cell toxicity of alloxan. Diabetologia 45: 1542-1549
7. De Vos A, Heimberg H, Quartier E, Huypens P, Bouwens L, Pipeleers D, Schuit F (1995) Human and rat beta cells differ in glucose transporter but not in glucokinase gene expression. J Clin Invest 96: 2489-2495
8. Ferrer J, Benito C, Gomis R (1995) Pancreatic islet GLUT2 glucose transporter mRNA and protein expression in humans with and without NIDDM. Diabetes 44: 1369-1374
9. Welsh N, Margulis B, Borg LA, Wiklund HJ, Saldeen J, Flodstrom M, Mello MA, Andersson A, Pipeleers DG, Hellerstrom C, Eizirik DL (1995) Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes mellitus. Mol Med 1: 806-820
10. Tiedge M, Lortz S, Drinkgern J, Lenzen S (1997) Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes 46: 1733-1742
11. Grankvist K, Lernmark A, Täljedal IB (1979) Trypan Blue as a marker of plasma membrane permeability in alloxan-treated mouse islet cells. J Endocrinol Invest 2: 139-145
12. Wilson GL, Patton NJ, McCord JM, Mullins DW, Mossman BT (1984) Mechanisms of streptozotocin-and alloxan-induced damage in rat B cells. Diabetologia 27: 587-591